Emerging Markets Reshape Global Pharmaceutical Map
This article was originally published in PharmAsia News
Executive Summary
There is new momentum in the market shift toward emerging countries, with the latest surge looking more disruptive to the industry business model than the earlier wave of interest surrounding revenue growth